Tick-borne encephalitis vaccine: FDA accepts for Priority Review Pfizer’s application for TicoVac
by Press Release from Outbreak News Today on (#5ENNB)
Pfizer Inc. recently announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company's Biologics License Application (BLA) for TicoVacTM, its tick-borne encephalitis (TBE) vaccine for active immunization to prevent TBE in individuals 1 year of age and older. If approved, TicoVac would be the first vaccine in the U.S. to help [...]
The post Tick-borne encephalitis vaccine: FDA accepts for Priority Review Pfizer's application for TicoVac appeared first on Outbreak News Today.